Streamline Health Solutions INC
Market Movers (8-K)
MDaudit has completed its acquisition of Streamline Health Solutions, Inc., converting each share into $5.34 cash and taking the company private.
Streamline Health Solutions, Inc. stockholders overwhelmingly approved the merger agreement with Mist Holding Co. and an advisory vote on executive compensation related to the transaction.
Streamline Health Solutions, Inc. and its subsidiaries have entered into a seventh modification of their loan agreement with Western Alliance Bank, adjusting financial covenants and securing a temporary increase in their revolving credit line, while also approving executive transaction bonuses related to an upcoming merger.
Worse than expected
Capital raise
Streamline Health Solutions, Inc. announced improved fiscal first quarter 2025 financial results and a definitive all-cash merger agreement to be acquired by MDaudit for approximately $37.4 million, representing a substantial premium for shareholders.
Better than expected
MDaudit has entered into a definitive merger agreement to acquire Streamline Health Solutions, Inc. for $5.34 per share in cash, representing a substantial premium for Streamline shareholders and aiming to create a unified healthcare revenue cycle platform.
Capital raise
Better than expected
Streamline Health Solutions reports a decrease in total revenue for fiscal year 2024 but aims for adjusted EBITDA positive run rate in the first half of fiscal 2025.
Worse than expected
Quarterly Earnings (10-Q)
Streamline Health Solutions Inc. reported a significant reduction in net loss and positive Adjusted EBITDA for the first quarter of fiscal year 2025, while simultaneously announcing a definitive merger agreement to be acquired by Mist Holding Co. for $5.34 per share in cash.
Capital raise
Worse than expected
Streamline Health Solutions reported a decrease in revenue for the third quarter of fiscal year 2025, alongside a strategic restructuring and a reverse stock split.
Worse than expected
Capital raise
Streamline Health Solutions reported a decrease in revenue for the second quarter of fiscal year 2025, alongside a net loss, as the company navigates strategic restructuring and a shift towards SaaS offerings.
Worse than expected
Capital raise
Streamline Health Solutions experienced a revenue decrease in the first quarter of fiscal year 2025, primarily due to a client non-renewal and a strategic shift towards SaaS products.
Worse than expected
Capital raise
Annual Reports (10-K)
Streamline Health Solutions, Inc. has filed an amendment to its annual report, providing comprehensive details on corporate governance, executive compensation, and director appointments, while disclosing that named executive officers did not receive cash bonuses for fiscal year 2024 due to not meeting adjusted EBITDA targets.
Worse than expected
Streamline Health Solutions, Inc. has filed an amendment to its annual report on Form 10-K for the fiscal year ended January 31, 2025, primarily to incorporate a newly adopted executive compensation clawback policy.
Streamline Health Solutions reports a decrease in revenue for fiscal year 2025, addresses going concern doubts, and focuses on strategic restructuring and SaaS growth.
Worse than expected
Capital raise
10-K: Streamline Health Solutions Reports Fiscal Year 2024 Results, Navigates Strategic Restructuring
Streamline Health Solutions reports a net loss of $18.7 million for fiscal year 2024, alongside a strategic restructuring aimed at reducing expenses and focusing on SaaS growth.
Worse than expected
Capital raise
Insider Trading (Form 4)
Director Kenan Lucas reports the disposition of all Streamline Health Solutions shares following the company's acquisition by Mist Holding Co. at $5.34 per share.
Streamline Health Solutions' Chief People Officer, Wendy L. Lovvorn, disposed of all her common stock holdings following the company's merger with Mist Holding Co. for $5.34 per share.
Streamline Health Solutions Executive Chairman Wyche T. Green III disposed of all beneficial ownership in the company following its acquisition by Mist Holding Co. for $5.34 per share.
Streamline Health Solutions CEO Benjamin Stilwill disposed of all shares following the company's merger with Mist Holding Co. at $5.34 per share.
Streamline Health Solutions CFO Bryant J. Reeves III disposed of 13,515 shares of common stock following the company's merger with Mist Holding Co. at $5.34 per share.
Director Jonathan Phillips reports disposition of shares and warrants due to Streamline Health's merger with Mist Holding Co.
Proxy Statements (Def-14A)
A healthcare technology solutions provider has entered into a definitive merger agreement to be acquired for $5.34 per share in cash, representing a significant premium to its recent trading price.
Better than expected
Capital raise
Streamline Health Solutions, Inc. announced improved fiscal first quarter 2025 financial results and a definitive all-cash merger agreement with MDaudit valued at approximately $37.4 million, offering a substantial premium to shareholders.
Better than expected
DEFA14A: Streamline Health Solutions to Merge with MDaudit in Strategic Healthcare Technology Acquisition
Streamline Health Solutions, Inc. has signed a definitive agreement to be acquired by MDaudit, aiming to enhance revenue cycle management and expand healthcare technology solutions.
MDaudit has entered into a definitive merger agreement to acquire Streamline Health Solutions, Inc. for $5.34 per share in cash, valuing the transaction at approximately $37.4 million including debt, and representing a significant premium for Streamline shareholders.
Better than expected
Streamline Health Solutions is asking stockholders to approve a reverse stock split to boost its share price and maintain its listing on The Nasdaq Capital Market.
DEF 14A: Streamline Health Solutions Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Streamline Health Solutions announces its 2024 Annual Meeting of Stockholders to be held virtually on June 13, 2024, featuring proposals including director elections, executive compensation, auditor ratification, and approval of a new incentive plan.
Schedule 13D - Activist Investments
Harbert Discovery Fund and related entities report zero beneficial ownership in Streamline Health Solutions Inc. following its acquisition by Mist Holding Co. for $5.34 per share.
SCHEDULE 13D/A: Harbert Discovery Fund Affirms Support for Streamline Health Solutions Merger with Mist Holding Co.
Harbert Discovery Fund and related entities have filed an amendment to their Schedule 13D, confirming their agreement to vote their 7.8% stake in Streamline Health Solutions Inc. in favor of the proposed merger with Mist Holding Co.
Schedule 13G - Passive Investments
Beryl Capital Management and its affiliates have reported a complete divestment of their beneficial ownership in Streamline Health Solutions Inc.
Worse than expected
Beryl Capital Management LLC, along with affiliated entities and control person David A. Witkin, has disclosed beneficial ownership of 8.6% of Streamline Health Solutions Inc.'s common stock.